CREO
COM:CREOMEDICAL
Creo Medical
- Stock
Last Close
16.63
25/11 09:13
Market Cap
1.19M
Beta: -
Volume Today
90.69K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Feb '14 | Feb '15 | Feb '16 | Jun '17 | Jun '18 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 45.67K - | 3.77M - | 7.66M 103.15% | 8.91M 16.41% | 8.71M 2.27% | |||||||
average payables | 160.72K - | 205.60K 27.93% | 847.47K 312.18% | 7.42M - | 9.94M 33.94% | 9.46M 4.83% | 3.40M 64.06% | |||||
average receivables | 5.70M - | |||||||||||
book value per share | 0.02 - | 0.01 45.56% | 0.04 330.52% | 0.24 511.57% | 0.53 - | 0.66 24.44% | 0.39 40.77% | 0.43 10.61% | 0.26 38.90% | 0.19 27.34% | ||
capex per share | -0.00 - | -0.00 42.70% | -0.00 139.62% | -0.00 108.22% | -0.01 178.13% | -0.02 52.30% | -0.01 42.15% | -0.00 59.81% | -0.04 906.62% | -0.02 51.51% | 0.00 122.00% | |
capex to depreciation | -0.69 - | -0.82 18.71% | -1.41 72.25% | -1.58 12.53% | -2.73 72.38% | -4.19 53.20% | -1.74 58.38% | -0.36 79.28% | -2.39 562.01% | -1.05 55.97% | 0.35 133.55% | |
capex to operating cash flow | 0.03 - | 0.03 14.61% | 0.05 74.40% | 0.03 30.01% | 0.12 270.52% | 0.10 19.16% | 0.09 3.54% | 0.04 62.47% | 0.24 564.91% | 0.13 44.32% | -0.06 142.39% | |
capex to revenue | -82.97 - | -0.06 99.93% | -0.24 298.13% | -0.12 50.47% | 0.04 132.33% | |||||||
cash per share | 0.01 - | 0.00 65.61% | 0.03 740.89% | 0.22 617.19% | 0.49 - | 0.64 30.56% | 0.28 56.63% | 0.26 8.52% | 0.07 72.72% | 0.06 15.21% | ||
days of inventory on hand | 332.93 - | 31.14K 9,254.70% | 460.98 98.52% | 228.64 50.40% | 242.30 5.98% | 190.74 21.28% | ||||||
days payables outstanding | 813.43 - | 209.15K 25,611.84% | 674.00 99.68% | 266.73 60.43% | 233.86 12.33% | 58.87 74.83% | ||||||
days sales outstanding | 75.84 - | |||||||||||
debt to assets | 0.01 - | 0.00 88.78% | 0.01 - | 0.01 3.56% | 0.13 1,526.33% | 0.10 20.59% | 0.16 47.80% | 0.09 41.91% | ||||
debt to equity | 0.01 - | 0.00 89.40% | 0.01 - | 0.01 6.06% | 0.20 2,167.61% | 0.14 26.81% | 0.24 64.25% | 0.12 51.21% | ||||
dividend yield | ||||||||||||
earnings yield | -0.03 - | -0.04 40.39% | -0.05 39.78% | -0.15 191.76% | -0.08 44.28% | -0.05 32.08% | -0.07 27.22% | -0.06 7.14% | -0.10 49.22% | -0.57 486.03% | -0.15 73.45% | |
enterprise value | 66.02M - | 66.60M 0.88% | 64.37M 3.35% | 39.81M 38.16% | 135.49M - | 147.25M 8.68% | 280.17M 90.27% | 220.89M 21.16% | 46.03M 79.16% | 149.28M 224.32% | ||
enterprise value over ebitda | -34.94 - | -23.75 32.02% | -17.43 26.60% | -4.55 73.92% | -11.67 - | -8.22 29.60% | -13.19 60.51% | -8.09 38.67% | -1.67 79.36% | -7.21 332.08% | ||
ev to operating cash flow | -48.49 - | -29.27 39.63% | -20.59 29.65% | -5.76 72.05% | -9.54 - | -12.42 30.16% | -17.21 38.53% | -8.49 50.66% | -1.84 78.31% | -6.91 275.13% | ||
ev to sales | 10.93K - | 29.71 99.73% | 8.78 70.45% | 1.69 80.70% | 4.85 186.09% | |||||||
free cash flow per share | -0.02 - | -0.03 66.37% | -0.04 40.06% | -0.11 193.53% | -0.09 18.52% | -0.17 84.51% | -0.10 40.22% | -0.10 1.30% | -0.19 80.63% | -0.15 20.26% | -0.07 50.72% | |
free cash flow yield | -0.02 - | -0.03 66.37% | -0.05 40.06% | -0.13 173.05% | -0.08 43.49% | -0.09 14.97% | -0.06 34.30% | -0.05 5.48% | -0.13 134.98% | -0.60 370.57% | -0.16 72.95% | |
graham net net | 0.01 - | 0.00 98.55% | 0.02 21,855.79% | 0.20 710.81% | 0.50 - | 0.60 20.49% | 0.11 81.70% | 0.12 9.09% | -0.04 136.17% | 0.03 177.47% | ||
graham number | 0.09 - | 0.08 12.57% | 0.19 145.31% | 0.81 337.97% | 1.14 - | 1.37 20.02% | 1.05 23.22% | 1.18 12.64% | 0.92 22.10% | 0.55 40.72% | ||
income quality | 0.68 - | 0.79 15.67% | 0.81 2.75% | 0.89 9.64% | 0.83 6.57% | 1.44 72.83% | 0.74 48.20% | 0.80 7.57% | 1.06 31.98% | 0.93 12.30% | 1.00 7.32% | |
intangibles to total assets | 0 - | 0 | 0 | 0.00 Infinity% | 0 100% | 0.01 Infinity% | 0.01 58.43% | 0.31 3,012.48% | 0.27 11.21% | 0.37 35.45% | 0.34 6.78% | |
interest coverage | -487.95K - | 7.41K 101.52% | -1.48K 120.01% | -830.43 43.95% | -1.35K 62.88% | -1.07K 20.90% | -368.01 65.60% | -133.26 63.79% | -64.59 51.53% | -107.16 65.90% | -62 42.14% | |
interest debt per share | 0.00 - | -0.00 9,825% | 0.00 8,880.21% | 0.00 2.14% | 0.00 - | 0.01 37.49% | 0.08 1,170.96% | 0.06 16.66% | 0.06 1.49% | 0.02 63.39% | ||
inventory turnover | 1.10 - | 0.01 98.93% | 0.79 6,656.13% | 1.60 101.62% | 1.51 5.64% | 1.91 27.03% | ||||||
invested capital | 0.01 - | 0.00 89.40% | 0.01 - | 0.01 6.06% | 0.20 2,167.61% | 0.14 26.81% | 0.24 64.25% | 63.30M 26,767,182,130.59% | ||||
market cap | 66.90M - | 66.90M 0% | 66.90M 0% | 53.48M 20.06% | 103.93M 94.33% | 179.65M 72.85% | 227.58M 26.68% | 312.90M 37.49% | 253.87M 18.87% | 47.44M 81.31% | 143.98M 203.48% | |
net current asset value | 1.24M - | 622.38K 49.62% | 3.01M 383.34% | 14.30M 375.42% | 46.48M - | 80.49M 73.18% | 29.81M 62.96% | 33.88M 13.63% | 7.75M 77.11% | 21.10M 172.15% | ||
net debt to ebitda | 0.47 - | 0.11 76.83% | 0.69 530.70% | 1.56 127.48% | 3.80 - | 4.48 17.86% | 1.54 65.62% | 1.21 21.64% | 0.05 95.75% | -0.26 599.37% | ||
net income per share | -0.02 - | -0.03 40.39% | -0.04 39.78% | -0.12 213.65% | -0.10 19.66% | -0.11 9.01% | -0.13 15.76% | -0.13 0.47% | -0.14 14.71% | -0.14 0.69% | -0.07 51.64% | |
operating cash flow per share | -0.02 - | -0.03 67.11% | -0.04 37.39% | -0.11 197.50% | -0.08 24.94% | -0.16 88.40% | -0.09 40.03% | -0.10 7.07% | -0.15 51.39% | -0.13 12.90% | -0.07 48.10% | |
payables turnover | 0.45 - | 0.00 99.61% | 0.54 30,930.51% | 1.37 152.69% | 1.56 14.06% | 6.20 297.24% | ||||||
receivables turnover | 4.81 - | |||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | -1.04 - | -2.28 118.42% | -0.89 61.12% | -0.48 45.65% | -0.20 - | -0.18 8.83% | -0.31 71.75% | -0.34 7.23% | -0.56 68.44% | -0.43 23.76% | ||
revenue per share | 0.00 - | 0.06 54,454.98% | 0.15 152.84% | 0.14 2.08% | 0.10 31.95% | |||||||
roe | -1.23 - | -3.18 157.87% | -1.03 67.53% | -0.53 48.71% | -0.21 - | -0.19 6.97% | -0.32 68.05% | -0.34 3.71% | -0.55 62.53% | -0.36 33.45% | ||
roic | -1.23 - | -3.19 158.09% | -1.01 68.15% | -0.53 47.91% | -0.21 - | -0.19 7.81% | -0.26 34.17% | -0.28 9.15% | -0.43 50.89% | -0.33 22.64% | ||
sales general and administrative to revenue | 1.41K - | 2.88 99.80% | 1.65 42.60% | 1.62 2.07% | 1.31 18.67% | |||||||
shareholders equity per share | 0.02 - | 0.01 45.56% | 0.04 330.52% | 0.24 511.57% | 0.53 - | 0.66 24.44% | 0.39 40.77% | 0.43 10.61% | 0.26 38.90% | 0.19 27.34% | ||
stock based compensation to revenue | 115.40 - | 0.08 99.93% | 0.10 31.96% | 0.05 49.51% | 0.04 24.28% | |||||||
tangible asset value | 1.37M - | 748.41K 45.56% | 3.22M 330.52% | 14.64M 354.42% | 47.41M - | 81.80M 72.55% | 34.28M 58.10% | 46.06M 34.38% | 21.76M 52.76% | 33.60M 54.41% | ||
tangible book value per share | 0.02 - | 0.01 45.56% | 0.04 330.52% | 0.24 511.11% | 0.52 - | 0.65 23.94% | 0.21 67.33% | 0.27 27.33% | 0.12 57.16% | 0.11 7.31% | ||
working capital | 1.24M - | 622.38K 49.62% | 3.03M 386.62% | 14.30M 372.27% | 46.87M - | 81.04M 72.89% | 38.67M 52.28% | 41.43M 7.13% | 16.20M 60.89% | 28M 72.80% |
All numbers in GBP (except ratios and percentages)